Trials / Unknown
UnknownNCT01132235
An Open-label Study to Evaluate the Efficacy of Re-treatment for Patients With a History of Etanercept Use
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Florida Academic Dermatology Centers · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy of re-treatment with etanercept 50mg subcutaneous injections twice weekly for 12 weeks in subjects who have previously been treated etanercept and efficacy diminished.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | etanercept | 50mgs subcutaneous injections twice a week for 12 weeks |
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2010-05-27
- Last updated
- 2010-05-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01132235. Inclusion in this directory is not an endorsement.